Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

The antidiabetic drug metformin has been proposed to affect non-alcoholic fatty liver disease (NAFLD) through its effects on intestinal microbiota and barrier function. However, so far most studies focused on long-term effects and more progressed disease stages. The aim of this study was to assess i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Brandt, Annette, Hernández-Arriaga, Angélica, Kehm, Richard, Sánchez, Victor, Jin, Cheng Jun, Nier, Anika, Baumann, Anja, Camarinha-Silva, Amélia, Bergheim, Ina
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491483/
https://ncbi.nlm.nih.gov/pubmed/31040374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-43228-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk